KCND2 and cardiac hypertrophy: In the hypertrophic ventricular myocardium in animal models of cardiac hypertrophy or patients with organic heart disease, especially in patients with co-existing heart failure and myocardial injury, the expression of Kv4.3 and Kv4.2 in ventricular myocytes is downregulated and the activity of Ito channels is reduced.